Latest posts

May 2, 2022, LINK Medical and Serendipity Partners announce a new partnership. Serendipity Partners (Serendipity) has been invited as a part owner of LINK Medical. Serendipity now owns 49% of

Join our breakfast meeting together with Medicon Village Alliance (MVA) in Copenhagen and meet our experts! When: May 24 Time: 9 to 11:15 Going from non-clinical to clinical is no

Join our webinar The Covid-19 pandemic has irreversibly changed the way clinical trials are conducted. The use of a wide range of technologies such as eConsent, teleconsultations, sensors, devices, and

When: March 29 Time: 10 to 11 CEST REGISTER and watch now When you register for the Q&A, you automatically get access to the short 16 minute video presentation and

The Partnership Program that has been established by Viedoc is designed to improve trial efficiency for LINK Medical and its clients. It allows for continuous exchange of experience, needs and

When: November 25th Time: 14:00 – 15:00 Where: Zoom webinar LINK Medical & Insife have created a partnership to offer easy and affordable clinical trial safety and pharmacovigilance solutions. In this webinar, you will learn how

LINK Medical is pleased to announce that Maria Hortlund joins the Market Access team as a RWE Manager. Maria has over 15 years’ experience within RWE in the Nordics. She

Uppsala, Sweden June 7th, 2021, – LINK Medical, a full-service contract research organization (CRO) providing product development and post-marketing services for the pharmaceutical and medical device industries, has signed a contract to

LINK Medical and Ectin Research AB have signed an agreement appointing LINK Medical Research AB to run the Phase I/II clinical study of the treatment of metastatic bladder cancer patients

OSLO, Norway/ESPOO, Finland May 24, 2021 – LINK Medical, the Northern European clinical research organization (CRO), and Medaffcon Oy, the expert service and research consultancy company based in Finland, announce

OSLO, Norway, May 03 2021 – LINK Medical, the Northern European clinical research organization (CRO), today announced the expansion of its regulatory team with the recent appointment of new regulatory